Caplin Point Laboratories Limited

NSE CAPLIPOINT.NS

Caplin Point Laboratories Limited Dividend Yield on January 14, 2025: 0.21%

Caplin Point Laboratories Limited Dividend Yield is 0.21% on January 14, 2025, a -24.35% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Caplin Point Laboratories Limited 52-week high Dividend Yield is 0.36% on June 04, 2024, which is 77.56% above the current Dividend Yield.
Caplin Point Laboratories Limited 52-week low Dividend Yield is 0.17% on January 07, 2025, which is -15.61% below the current Dividend Yield.
Caplin Point Laboratories Limited average Dividend Yield for the last 52 weeks is 0.27%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NSE: CAPLIPOINT.NS

Caplin Point Laboratories Limited

CEO	Dr. Sridhar Ganesan
IPO Date	June 23, 2014
Location	India
Headquarters	Ashvich Tower
Employees	3,406
Sector	Health Care
Industries Pharmaceuticals Consumer Packaged Goods Cosmetics

Description

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.

Key trends

Past 5 years